The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer.
 
David D. Chism
No Relationships to Disclose
 
Biren Saraiya
Honoraria - Eisai
Research Funding - Merck (Inst); Regeneron (Inst)
 
Tanya B. Dorff
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer; Exelixis; Janssen Oncology; Pfizer; Sanofi/Aventis; Seagen
Research Funding - Pfizer (Inst)
 
Brendan D. Curti
Honoraria - Clinigen Group; Sanofi
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb (Inst); Clinigen Group (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
 
Edwin Melencio Posadas
Consulting or Advisory Role - Bayer; CytoLumina; Myovant Sciences
Speakers' Bureau - Bayer
Research Funding - PFizer
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
 
Carlyle St. Paul
No Relationships to Disclose
 
Subhendu Mukhopadhyay
No Relationships to Disclose
 
Leena Desai
No Relationships to Disclose
 
Henning Lauterbach
No Relationships to Disclose
 
Rounak Nassirpour
No Relationships to Disclose
 
Alexander Grill
No Relationships to Disclose
 
Ali Manouchehri
No Relationships to Disclose
 
Kia Katchar
Employment - Hookipa Pharma
Stock and Other Ownership Interests - Hookipa Pharma
 
Kevin Hibbert
No Relationships to Disclose
 
Katia Schlienger
Employment - Hookipa Pharma; Merck
Stock and Other Ownership Interests - Hookipa Pharma; Merck
Patents, Royalties, Other Intellectual Property - Hookipa Pharma
Travel, Accommodations, Expenses - Hookipa Pharma; Merck
 
Susan F. Slovin
Consulting or Advisory Role - Bayer; Clovis Oncology; Pfizer
Speakers' Bureau - OncLive; PER; Prime Oncology; Society for Immunotherapy of Cancer
Research Funding - AstraZeneca